| Metric | შპს ნიუ ფარმა NEW PHARMA | შპს მედიმექსი |
|---|---|---|
| Growth | ||
| Revenue | ₾5.0m₾0 | ₾1.3m₾2.0m |
| Revenue growth | — | -35.1% |
| Profitability | ||
| EBITDA | -₾1.5m₾0 | ₾470k₾1.1m |
| EBITDA margin | -29.7% | 36.2%57.4% |
| Net profit | -₾1.5m₾0 | ₾8.8m-₾580k |
| Net margin | -29.7% | 675.1%-28.9% |
| Balance sheet | ||
| Total assets | ₾649k₾2.4m | ₾11.5m₾16.8m |
| Total equity | -₾1.1m₾357k | ₾11.2m₾208k |
| ROE | —0.0% | 78.2%-279.0% |